Skip to main content
:::
  • HOME
  • News
  • CH Biotech R&D Co., LTD. Invests NT$150 million to Launch the World’s First Agriculture Sustainability–Focused Mass Spectrometry AI Center with National Chung Hsing University

CH Biotech R&D Co., LTD. Invests NT$150 million to Launch the World’s First Agriculture Sustainability–Focused Mass Spectrometry AI Center with National Chung Hsing University

2025-12-16
興新聞張貼者
Unit秘書室
53
CH Biotech and National Chung Hsing University (NCHU) have joined forces to establish the world’s first Mass Spectrometry–based Multi-omics and Artificial Intelligence Research Center (MS-AI Center) dedicated to advancing agricultural sustainability. The collaboration was formalized at a signing ceremony attended by NCHU President Fu-Chih Chan and CH Biotech Chairman Cheng-Pang Danny Wu. CH Biotech Co. is investing NT$150 million to support the center’s core research and development programs.

Global warming is an irreversible trend, and climate change is already transforming agricultural ecosystems worldwide. International bodies such as the FAO (Food and Agriculture Organization of the United Nations) and the IPCC (Intergovernmental Panel on Climate Change) highlight that climate variability is a key factor in reduced crop yields, lower quality, and impaired plant performance. At the recent World Biostimulants Congress in Barcelona, Spain, experts agreed that improving crops’ intrinsic climate resilience is essential for achieving low-input, high-resilience agriculture—a goal long central to CH Biotech’s mission.

The new MS-AI Center will feature more than four high-performance liquid chromatography–tandem mass spectrometry (LC–MS/MS) systems, matching the most advanced specifications available in Taiwan. By integrating peptidomics, metabolomics, and lipidomics platforms with AI-powered predictive models, the center aims to create a complete pipeline from molecular analysis → functional validation → field application. This is the first time multi-omics and AI are being systematically applied to crop climate resilience research, setting a global benchmark for scientific rigor and innovation in agriculture.

Driving Precision Research for CH Biotech’s Three Crop Resilience Systems
CH Biotech has long focused on three core resilience systems using various molecules: Homeostatic SysteminsTM peptides, oligosaccharides, and short-chain lipids. These technologies strengthen photosynthesis, energy use, and nutrient uptake, enhance cell wall integrity, antioxidant capacity, and stress adaptation, and facilitate rapid inter-plant chemical communication via mobile peptides and lipid signals.

The MS-AI Center will be led by Professor Ying-Lan Chen, a national expert in mass spectrometry–based multi-omics. In collaboration with CH Biotech, the center will develop optimized multi-omics platforms tailored to these three resilience systems, including peptide identification, stress-response metabolic pathway mapping, lipid signaling modeling, and functional prediction. These efforts will transform CH Biotech’s crop resilience solutions from experience-driven approaches into data-driven, scientifically validated, and quantifiable precision agriculture technologies.

Advancing Smart and Sustainable Agriculture in Taiwan
The MS-AI Center will drive innovation in four key areas: research and development, smart decision-making, interdisciplinary talent cultivation, and circular sustainability. By combining high-resolution mass spectrometry with AI, the center will accelerate product development, create predictive models for crop stress responses, train multi-omics and AI specialists, and convert agricultural by-products into green bioactive compounds—paving the way for a circular agricultural economy.

In the face of global climate uncertainty, this integrated platform will strengthen Taiwan’s agricultural science capacity, ensure the reliability and scalability of crop solutions, and establish a new standard for precision, science-driven, and sustainable agriculture.
NCHU President Fuh-Jyh Jan (right) and CH Biotech Chairman Cheng-Pang Danny Wu (left) sign the agreement

NCHU President Fuh-Jyh Jan (right) and CH Biotech Chairman Cheng-Pang Danny Wu (left) sign the agreement

Group photo at the signing ceremony.

Group photo at the signing ceremony.

NCHU President Fuh-Jyh Jan (right) and CH Biotech Chairman Cheng-Pang Danny Wu (left) sign the agreement

NCHU President Fuh-Jyh Jan (right) and CH Biotech Chairman Cheng-Pang Danny Wu (left) sign the agreement

Back